Free Trial
NYSE:SYK

Stryker Q2 2025 Earnings Report

Stryker logo
$400.44 +0.03 (+0.01%)
As of 10:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Upcoming Event
Earnings Conference Call
Stryker Q2 2025
00:00 / 00:00
Live Transcript
Follow Audio

Stryker EPS Results

Actual EPS
N/A
Consensus EPS
$3.06
Beat/Miss
N/A
One Year Ago EPS
N/A

Stryker Revenue Results

Actual Revenue
N/A
Expected Revenue
$5.92 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Stryker Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Thursday, July 31, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Stryker Earnings Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Top 15 Low Volatility Healthcare Stocks to Buy Now
See More Stryker Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Stryker? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stryker and other key companies, straight to your email.

About Stryker

Stryker (NYSE:SYK) operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

View Stryker Profile

More Earnings Resources from MarketBeat